Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$260K Buy
3,674
+17
+0.5% +$1.27K 0.13% 117
2025
Q4
$289K Sell
3,657
-7
-0.2% -$554 0.15% 110
2025
Q3
$302K Buy
3,664
+24
+0.7% +$1.89K 0.16% 107
2025
Q2
$293K Sell
3,640
-238
-6% -$18.4K 0.17% 104
2025
Q1
$311K Buy
3,878
+249
+7% +$20.7K 0.19% 93
2024
Q4
$297K Buy
3,629
+63
+2% +$5.24K 0.18% 96
2024
Q3
$294K Buy
3,566
+105
+3% +$7.84K 0.18% 97
2024
Q2
$243K Buy
3,461
+59
+2% +$4.21K 0.16% 103
2024
Q1
$252K Buy
3,402
+43
+1% +$3K 0.17% 99
2023
Q4
$222K Buy
+3,359
New +$210K 0.16% 100
2023
Q1
Sell
-3,300
Closed -$239K 108
2022
Q4
$239K Buy
+3,300
New +$236K 0.2% 96
2022
Q3
Sell
-3,278
Closed -$205K 106
2022
Q2
$205K Buy
3,278
+48
+1% +$3.18K 0.18% 102
2022
Q1
$227K Buy
+3,230
New +$218K 0.17% 97

Other funds holding MET

W Advisors LLC's MET Position: Q1 2026 in Review

W Advisors LLC increased its MetLife (MET) stake by 0.46% in Q1 2026, buying an estimated $1.27K and bringing the position to 3,674 shares worth $260K. The position accounts for 0.13% of the portfolio, ranked #117.

W Advisors LLC first reported a position in MET in Q1 2022 and has held it in 13 quarters since. The position peaked at $311K in Q1 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • W Advisors LLC held 3,674 shares of MetLife worth $260K as of Q1 2026.
  • W Advisors LLC bought 17 MetLife shares in Q1 2026, an estimated $1.27K.
  • MetLife made up 0.13% of W Advisors LLC's portfolio in Q1 2026, its #117 holding.
  • W Advisors LLC first reported a position in MetLife in Q1 2022 and has held it in 13 quarters since.
  • W Advisors LLC's MetLife position peaked at $311K in Q1 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on W Advisors LLC's 13F filing for Q1 2026, filed 29 Apr 2026.